Charles Schwab Investment Management Inc Moderna, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,344,203 shares of MRNA stock, worth $76.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,344,203
Previous 2,132,777
9.91%
Holding current value
$76.6 Million
Previous $143 Million
31.62%
% of portfolio
0.02%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding MRNA
# of Institutions
927Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.32 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$835 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$574 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$239 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...